Optimizing conventional DMARD therapy for Sjögren's syndrome

Autoimmun Rev. 2018 May;17(5):480-492. doi: 10.1016/j.autrev.2018.03.003. Epub 2018 Mar 9.
No abstract available

Keywords: Combination therapy; Conventional disease modifying anti rheumatic drugs; Hydroxychloroquine; Leflunomide; Primary Sjögren's syndrome.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antirheumatic Agents / therapeutic use*
  • Humans
  • Sjogren's Syndrome / drug therapy*
  • Sjogren's Syndrome / immunology

Substances

  • Antirheumatic Agents